ParaGen Technologies is the parent of a family of companies focused on diverse clinical areas including wound care, orthopedics, peripheral vascular and hernia repair. ParaGen aims to redefine tissue engineering by addressing the problems associated with synthetic and biologic implants, while incorporating their advantages. The company is utilizing synthetic nanofiber scaffolds that promote healing by mimicking the physical structures found naturally in the body. This technology is tailored to meet the needs of specific clinical verticals.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/07/17 | $4,100,000 | Seed |
Ikove Venture Partners | undisclosed |
| 11/29/18 | $3,000,000 | Bridge |
Igor Sill | undisclosed |
